Recently, several studies have reported that TFF3 promotes a CSC-like phenotype in pancreatic, colorectal, hepatocellular, lung, cervical, and ER+ mammary carcinoma [10, 12, 13, 15, 18–20]. This evidence concerns the gene TFF3 and breast carcinoma.